Clinical Trials for Early Small (cT1N0) Triple Negative Breast Cancer

Find clinical trials for early small (ct1n0) triple negative breast cancer. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

NCT ID: NCT05215106

This clinical trial, called POP-Durva, is studying a treatment called Durvalumab for women with early small triple negative breast cancer, which is a type of breast cancer that does not respond to ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bordeaux, , France, Villejuif, , France +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions